Company intelligence / Profile preview

Hobart Healthcare

Geneva, Switzerland

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Hobart Healthcare is a holding and development company that builds, funds and guides a portfolio of medical device and health‑technology companies in cardiology, diabetes, oncology, neurology, rehabilitation and other chronic diseases. Several portfolio companies have reached commercial stage globally (e.g., CE mark approvals, U.S. commercialization) and multiple exits via mergers with large strategics, including Johnson & Johnson and Philips, indicating clinically validated technologies across cardiology, imaging and neuromodulation.[2][8]

Therapeutic areas: ImmunologyEndocrinologyCardiovascularNeurologyGastroenterologyMetabolic DisordersOncology
Modalities: DeviceBiologicSmall molecule
Industry: Investors

Partnerships

Johnson & Johnson (via Biosense-Webster exit)[8]Philips (via EPD Solutions exit)[8]

Beyond the preview

Go deeper on Hobart Healthcare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hobart Healthcare.

Explore the full profile